Universal Detection Technology (UNDT) Stock Price, News & Analysis

Company Overview

Universal Detection Technology, Inc. develops and commercializes diagnostic assays and therapeutic technologies to address infectious diseases. The company’s core offerings include a range of proprietary molecular detection kits utilizing ligase detection technology (LDT) for rapid and accurate identification of viral and bacterial pathogens in clinical and veterinary settings. In addition to diagnostic assays, the company provides contract research and development services, leveraging its technical platform to support custom assay design, validation and regulatory submissions for partners in the healthcare and agricultural sectors.

Since its founding in 2004, Universal Detection Technology has expanded its product pipeline to cover key areas such as foodborne pathogen testing, veterinary vaccine research and specialized reagent manufacturing. Its diagnostics portfolio targets pathogens including Salmonella, Listeria and African swine fever virus, with an emphasis on speed, sensitivity and ease of use. The company’s research laboratories in California and Shanghai work in collaboration with academic institutions, government agencies and commercial partners to advance novel detection methodologies and accelerate product commercialization.

Universal Detection Technology’s offerings are sold through its in-house sales organization and through distribution agreements in Europe, Latin America and parts of Asia, supporting a customer base of clinical diagnostic labs, public health agencies and livestock producers. To enhance global reach and regulatory compliance, the company maintains quality systems in accordance with international standards and engages in continuous validation efforts to meet evolving market requirements.

The company is managed by an executive team with extensive experience in molecular diagnostics and immunology. The President and CEO brings over two decades of industry expertise in assay development and regulatory affairs, while the Chief Scientific Officer oversees research initiatives and pipeline strategy. Together, this leadership team guides Universal Detection Technology’s mission to deliver innovative solutions for disease detection, prevention and control worldwide.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1,800 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

UNDT Stock Analysis - Frequently Asked Questions

How do I buy shares of Universal Detection Technology?

Shares of UNDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Universal Detection Technology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Universal Detection Technology investors own include BIO-key International (BKYI), Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Adamis Pharmaceuticals (ADMP) and Digital Ally Inc./NV (DGLY).

Company Calendar

• Today: 7/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: POLLUTION CNTRL
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:UNDT
• CIK: 763950
• Web: www.udetection.com
• Phone: 310-248-3655
• Fax: 310-273-2662
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A